title: Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease?
abstract: Hypertrophic gastropathy--that is, Ménétrier's disease--was found, in a retrospective analysis, to be associated with Helicobacter pylori in more than 90% of patients. It is proposed that hypertrophic gastropathy represents a special form of H pylori gastritis in these patients. A case is described of a 28 year old woman with Ménétrier's disease associated with proved protein loss from the stomach. Treatment with cimetidine for more than three years had little benefit when colonisation by H pylori was detected. Density of H pylori colonisation and activity of gastritis, which was also present in the first biopsy specimens taken five years ago, were more pronounced in the body than in the antrum, which is in agreement with the characteristics of H pylori gastritis found in other cases with Ménétrier's disease. A 14 day antibacterial treatment course with 750 mg amoxicillin three times a day combined with 40 mg omeprazole three times a day was started in April 1991. This resulted in eradication of H pylori and the return to normal of giant folds and the mucosal histology. Serum protein concentrations returned to normal within six weeks and remained normal at two endoscopies during a two year follow up. This case report suggests that a subgroup of the patients with Ménétrier's disease may be healed by the eradication of H pylori.
authors.affiliation: Medical Department II, Klinikum Grosshadern, University of Munich, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Bayerdörffer
authors.forename: M M
authors.initials: MM
authors.lastname: Ritter
authors.forename: R
authors.initials: R
authors.lastname: Hatz
authors.forename: W
authors.initials: W
authors.lastname: Brooks
authors.forename: G
authors.initials: G
authors.lastname: Ruckdeschel
authors.forename: M
authors.initials: M
authors.lastname: Stolte
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005758:Gastritis, Hypertrophic / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use*; D011504:Protein-Losing Enteropathies / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000658:Amoxicillin; D009853:Omeprazole